Biora Therapeutics, Inc.
BIOR · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $225 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $225 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -89.9% | -41.3% | -37.8% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 65.4% | 100% | -13.4% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -50,709.4% | 2,270.1% | -236% | -1,579.1% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -57,506.3% | 2,033% | -772.9% | -1,767.5% |
| EPS Diluted | -5.04 | 0 | -0.14 | -0.62 |
| % Growth | – | 100% | 77.4% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |